Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production

• James R. Tribble,
• Melissa Jöe,
• Carmine Varricchio,
• Amin Otmani,
• Alessio Canovai,
• Baninia Habchi,
• Evangelia Daskalakis,
• Romanas Chaleckis,
• Andrea Loreto,
• Jonathan Gilley,
• Craig E. Wheelock,
• Gauti Jóhannesson,
• Raymond C. B. Wong,
• Michael P. Coleman,
• Andrea Brancale,
• Pete A. Williams

Affiliations

James R. Tribble

Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet

Melissa Jöe

Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet

Carmine Varricchio

School of Pharmacy and Pharmaceutical Sciences; Cardiff University

Amin Otmani

Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet

Alessio Canovai

Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet

Baninia Habchi

Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute

Evangelia Daskalakis

Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute

Romanas Chaleckis

Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute

Andrea Loreto

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge

Jonathan Gilley

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge

Craig E. Wheelock

Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute

Gauti Jóhannesson

Department of Clinical Sciences, Ophthalmology, Umeå University

Raymond C. B. Wong

Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital

Michael P. Coleman

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge

Andrea Brancale

School of Pharmacy and Pharmaceutical Sciences; Cardiff University

Pete A. Williams

Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet